Advertisement

Comparison of Hospital Outcomes of Transcatheter AorticValve Implantation With Versus Without Hypothyroidism

      Comparative outcomes of transcatheter aortic valve implantation (TAVI) in patients with and without hypothyroidism were not previously reported. This study aimed to appraise the clinical outcomes and impact of hypothyroidism on patients who underwent TAVI. Patients with hypothyroidism who underwent TAVI from 2011 to 2014 were identified in the National Inpatient Sample database using the International Classification of Diseases, ninth Revision, Clinical Modification. The primary outcome was the effect of hypothyroidism on inpatient mortality. Secondary outcomes were the impact of hypothyroidism on post-TAVI complications. We also evaluated the length of hospital stay and the cost of hospitalization. Propensity score-matched analysis was performed to address potential confounding. The hypothyroid patients who underwent TAVI had no significant increase in the risk of in-hospital mortality (odds ratio 0.78; 95% confidence interval 0.51 to 1.21, p = 0.282), or most postprocedural complications. However, hypothyroid patients were more likely to develop hemorrhage requiring transfusion (odds ratio 1.36, 95% confidence interval 1.05 to 1.76, p = 0.043). In conclusion, TAVI is a feasible and relatively safe alternative with reasonable in-hospital outcomes in patients with hypothyroidism and severe symptomatic aortic stenosis. However, hypothyroid patients are more likely to require a blood transfusion after TAVI. Additional randomized trials are needed to evaluate TAVR outcomes in hypothyroid patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hollowell JG
        • Staehling NW
        • Flanders WD
        • Hannon WH
        • Gunter EW
        • Spencer CA
        • Braverman LE
        Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).
        J Clin Endocrinol Metab. 2002; 87: 489-499
        • Stathatos N
        • Wartofsky L
        Perioperative management of patients with hypothyroidism.
        Endocrinol Metab Clin North Am. 2003; 32: 503-518
        • Ranasinghe AM
        • Bonser RS
        Thyroid hormone in cardiac surgery.
        Vascul Pharmacol. 2010; 52: 131-137
        • Munk K
        • Sorensen SH
        • Andersen NH
        • Hansen TK
        • Norgaard BL
        Heart failure after aortic valve substitution due to severe hypothyroidism.
        Int J Cardiol. 2008; 127: e164-e166
        • Edwards FH
        • Cohen DJ
        • O'Brien SM
        • Peterson ED
        • Mack MJ
        • Shahian DM
        • Grover FL
        • Tuzcu EM
        • Thourani VH
        • Carroll J
        • Brennan JM
        • Brindis RG
        • Rumsfeld J
        • Holmes Jr., DR
        Steering committee of the society of thoracic surgeons/American college of cardiology transcatheter valve therapy R. development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement.
        JAMA Cardiol. 2016; 1: 46-52
      1. STS/ACC. Tools.acc.org. (2016). TAVR in-hospital mortality risk calculator. [online] Available at: http://tools.acc.org/tavrrisk/#!/content/evaluate/ [Accessed 14 March, 2018].

        • Popoveniuc G
        • Chandra T
        • Sud A
        • Sharma M
        • Blackman MR
        • Burman KD
        • Mete M
        • Desale S
        • Wartofsky L
        A diagnostic scoring system for myxedema coma.
        Endocr Pract. 2014; 20: 808-817
        • Rockville M
        HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP).
        Agency for Healthcare Research and Quality, Rockville, MD2012 (2012)
        • McDonald KM
        • Romano PS
        • Geppert J
        • Davies SM
        • Duncan BW
        • Shojania KG
        • Hansen A
        Measures of Patient Safety Based on Hospital Administrative Data – The Patient Safety Indicators.
        AHRQ Technical Reviews, Rockville (MD)2002
        • Romano PS
        • Geppert JJ
        • Davies S
        • Miller MR
        • Elixhauser A
        • McDonald KM
        A national profile of patient safety in U.S. hospitals.
        Health Aff. 2003; 22: 154-166
        • Austin PC
        An introduction to propensity score methods for reducing the effects of confounding in observational studies.
        Multivariate Behav Res. 2011; 46: 399-424
        • Mathew V
        • Misgar RA
        • Ghosh S
        • Mukhopadhyay P
        • Roychowdhury P
        • Pandit K
        • Mukhopadhyay S
        • Chowdhury S
        Myxedema coma: a new look into an old crisis.
        J Thyroid Res. 2011; 2011493462
        • O'Connor CJ
        • March R
        • Tuman KJ
        Severe myxedema after cardiopulmonary bypass.
        Anesth Analg. 2003; 96 (table of contents): 62-64
        • Sarma AK
        • Krishna M
        • Karunakaran J
        • Neema PK
        • Neelakandhan KS
        Severe hypothyroidism after coronary artery bypass grafting.
        Ann Thorac Surg. 2005; 80: 714-716
        • Cerillo AG
        • Storti S
        • Clerico A
        • Iervasi G
        Thyroid function and cardiac surgery: what should we measure, and when.
        Ann Thorac Surg. 2010; 89 (author reply 1-2): 1010-1011
        • Adams DH
        • Popma JJ
        • Reardon MJ
        Transcatheter aortic-valve replacement with a self-expanding prosthesis.
        N Engl J Med. 2014; 371: 967-968
        • Patel PA
        • Ackermann AM
        • Augoustides JGT
        • Ender J
        • Gutsche JT
        • Giri J
        • Vallabhajosyula P
        • Desai ND
        • Kostibas M
        • Brady MB
        • Eoh EJ
        • Gaca JG
        • Thompson A
        • Fitzsimons MG
        Anesthetic evolution in transcatheter aortic valve replacement: expert perspectives from high-volume academic centers in Europe and the United States.
        J Cardiothorac Vasc Anesth. 2017; 31: 777-790
        • Sherman SI
        • Ladenson PW
        Percutaneous transluminal coronary angioplasty in hypothyroidism.
        Am J Med. 1991; 90: 367-370
        • Martinez-Comendador J
        • Marcos-Vidal JM
        • Gualis J
        • Martin CE
        • Martin E
        • Otero J
        • Castano M
        Subclinical hypothyroidism might increase the risk of postoperative atrial fibrillation after aortic valve replacement.
        Thorac Cardiovasc Surg. 2016; 64: 427-433
        • Drucker DJ
        • Burrow GN
        Cardiovascular surgery in the hypothyroid patient.
        Arch Intern Med. 1985; 145: 1585-1587
        • Myerowitz PD
        • Kamienski RW
        • Swanson DK
        • Chopra PS
        • Berkoff HA
        • Kroncke GM
        • Rowe GG
        • Vander Ark CR
        • Dhanani SP
        Diagnosis and management of the hypothyroid patient with chest pain.
        J Thorac Cardiovasc Surg. 1983; 86: 57-60
        • Park YJ
        • Yoon JW
        • Kim KI
        • Lee YJ
        • Kim KW
        • Choi SH
        • Lim S
        • Choi DJ
        • Park KH
        • Choh JH
        • Jang HC
        • Kim SY
        • Cho BY
        • Lim C
        Subclinical hypothyroidism might increase the risk of transient atrial fibrillation after coronary artery bypass grafting.
        Ann Thorac Surg. 2009; 87: 1846-1852
        • Syed AU
        • El Watidy AF
        • Akhlaque NB
        • Wahba A
        • El Oakley RM
        • Imran K
        • Al Bukhari EA
        • Al Fagih MR
        Coronary bypass surgery in patients on thyroxin replacement therapy.
        Asian Cardiovasc Thorac Ann. 2002; 10: 107-110
        • Squizzato A
        • Romualdi E
        • Buller HR
        • Gerdes VE
        Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review.
        J Clin Endocrinol Metab. 2007; 92: 2415-2420
        • Manfredi E
        • van Zaane B
        • Gerdes VE
        • Brandjes DP
        • Squizzato A
        Hypothyroidism and acquired von Willebrand's syndrome: a systematic review.
        Haemophilia. 2008; 14: 423-433
        • Das KC
        • Mukherjee M
        • Sarkar TK
        • Dash RJ
        • Rastogi GK
        Erythropoiesis and erythropoietin in hypo- and hyperthyroidism.
        J Clin Endocrinol Metab. 1975; 40: 211-220
        • Carvalho GA
        • Paz-Filho G
        • Mesa Junior CO
        • Graf H
        Management of endocrine disease: pitfalls on the replacement therapy for primary and central hypothyroidism in adults.
        Eur J Endocrinol. 2018;
        • Sarrazin MS
        • Rosenthal GE
        Finding pure and simple truths with administrative data.
        JAMA. 2012; 307: 1433-1435